tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EKF Diagnostics Tightens Share Count with Treasury Buyback and Manages Major Holder’s Stake

Story Highlights
  • EKF Diagnostics repurchased 71,000 shares into treasury at 25.5p, trimming free-float voting stock.
  • The buyback included 21,000 shares from Harwood-managed funds to keep director Christopher Mills’ indirect stake near 30%.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EKF Diagnostics Tightens Share Count with Treasury Buyback and Manages Major Holder’s Stake

Claim 70% Off TipRanks Premium

EKF Diagnostics Holdings ( (GB:EKF) ) has shared an update.

EKF Diagnostics Holdings has bought back 71,000 of its own ordinary shares at 25.5 pence each, all of which will be held in treasury, reducing the number of shares in circulation to 434,651,112 with voting rights. As part of the transaction, the company acquired 21,000 shares from funds managed by Harwood to ensure that non-executive director Christopher Mills’ aggregate indirect interest remains around, but does not exceed, 30% of EKF’s total voting rights, leaving him with an indirect holding of 128,172,000 shares, a move that consolidates the capital structure while managing a significant shareholder’s regulatory threshold.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £27.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings is an AIM-listed global diagnostics business specialising in point-of-care analysers for haematology and diabetes, as well as life sciences services that manufacture specialist enzymes and custom products for diagnostic, food and industrial applications. Headquartered in Penarth near Cardiff, the company operates five manufacturing sites across the US and Germany and sells into more than 120 countries worldwide.

Average Trading Volume: 498,170

Technical Sentiment Signal: Strong Sell

Current Market Cap: £110.9M

See more data about EKF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1